Sentences with phrase «medicine company focused»

ViaCyte is a privately held, clinical - stage regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes.

RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX.V: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today the publication of a paper out of the University of Calgary in conjunction with co-authors from Kyoto University and the University of North Carolina, which further validates the company's ongoing clinical research using dermal sheath cup (DSC) cells to reverse the effects of pattern baldness.

ViaCyte is a privately - held, clinical - stage regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes.

San Diego, California, October 29, 2013 — ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty foreign.

Not exact matches

So when she discovered that year two of her rotation would focus mostly on surgery, Holly decided to take a break from medicine and give working for her dad's company a try.

Perth - based regenerative medicine company Avita Medical says it will be able to focus more on its core ReCell technology after completing the sale of its respiratory business for $ 2.47 million.

Valeant's playbook has focused on acquiring companies that produce lower - risk over-the-counter medicines that won't gobble up tremendous amounts of capital to launch.

The memory - eating disease, expected to afflict 15 million Americans by 2060 (and tens of millions more around the world as life expectancy increases), has no cure; a new drug for the condition hasn't been approved in well over a decade; initially promising experimental treatments seem to be failing with clockwork regularity; and there's not even a definitive consensus on what, exactly, biopharma companies should focus on while developing Alzheimer's medicines.

• Semma Therapeutics, a Cambridge, Mass. - based biotechnology company focused on the development of novel regenerative medicines, raised $ 114 million in Series B funding.

• Outpost Medicine, an Indianapolis and London - based biopharmaceutical company focused on treating urologic and gastrointestinal disorders, raised $ 20 million in funding.

Founded in 1994, Exelixis, Inc. (NASDAQ: EXEL) is a commercially successful, oncology - focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult - to - treat cancers.

The company focuses on cancer drug research and has a platform for so - called «real - world» data, which can be used to assess the economic value of medicines and is sought after by drug makers looking to justify their prices to health insurers.

IDEAYA Biosciences, Inc., an oncology - focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines and immuno - oncology therapies, announced today the successful completion of a $ 94 million crossover Series B financing.

The automated synthesis technology has been licensed to REVOLUTION Medicines, Inc., a company that Burke co-founded that focuses on creating new medicines based on small molecules found in nature.

Currently focused on an array of initiatives in energy, public health, and global poverty, Google.org tapped Larry Brilliant, a doctor specializing in preventive medicine and public health and the former CEO of two public companies, to serve as its executive director.

Asterias Biotherapeutics is a growing and dynamic biotechnology company focusing in the cutting edge field of regenerative medicine.

ViaCyte, a private company that has emerged as a leader in the field of regenerative medicine, is currently focused on developing a novel cell therapy for the treatment of diabetes.

She was the founder and CEO of two innovative healthcare companies: DNA Direct, the first medical genetics company to focus on bringing personalized medicine to the consumer, and Direct Medical Knowledge, a consumer health web site unique for its content depth and innovative search interface.

The firm was established in 2014 by Dr. Ed Bosarge to organize and manage investments in potentially game - changing bio-technology and healthcare companies focused on regenerative medicine, anti-aging and immunotherapy.

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self - renewal properties of the body through specific control of the Wnt signaling pathway.

However, since a diet can not be patented, mainstream medicine has instead focused on pharmaceutical drugs and vaccines to combat diseases like Alzheimer's, as such drugs are seen as a financial windfall for pharmaceutical companies, with so many Americans in the «Baby Boomer» age group entering into their senior years.

But that is a system dependent on taxes and there is still debate about how much people should pay into the system, doctors entering private medicine and making millions, focusing more on preventative care and alternative medicine, the role of the pharmaceutical companies.

The focus of the family - owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

He has also served as Director for Cancer Immunology and Immunotherapy for the Donald Monk Cancer Research Foundation; he is a partner at Veterinary Research Associates, LLC, a company focused on development and implementation of diagnostics for veterinary medicine and a founder / scientist at ApopLogic Pharmaceuticals, Inc, a biotechnology company focused on development of cancer therapeutics.

Vet - Stem, a company focused on bringing regenerative medicine technology to veterinarians, has developed a therapy to treat arthritis in dogs using the pet's own fat tissue!

«We wanted to build a company that would provide all the business support necessary for the veterinarians to focus on the parts of their job that they trained for: medicine and patient care.

The focus of the family - owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Coming from a family focused on human medicine — his father worked in the medical department of an oil company and his mother was a nurse — Roussel's decision to become a large animal veterinarian came as a surprise.

For instance, if the company focuses on biologics rather than medicines with broad appeal, you need to mention this as it is a huge differentiating factor for the company.